The estrogen receptor-α agonist PPT decreases cardiac myofilament activation. by Justyna Kulpa (313372)

“…EC₅₀ values were increased, demonstrating a decrease in myofilament calcium sensitivity. …”

Exogenous serotonin inhibits the Dar phenotype and decreases pathogen clearance rates. by Alexandra Anderson (97972)

“…<p>Adult wild type animals were exposed to <i>M. nematophilum</i> on plates containing exogenous serotonin and the Dar phenotype was scored in their progeny. Treatment with 3.8 mg/ml 5-HT caused a 35% decrease in the number of Dar animals following <i>M. nematophilum</i> infection using standard assay conditions (small lawn) (A). …”

Sulpiride decreases anterior pituitary cell proliferation <i>in vivo</i>. by Jimena Ferraris (314722)

siRNA Knockdown of PKCδ decreases phosphorylation of VEEV capsid. by Brian D. Carey (6092747)

IgG-mediated systemic anaphylaxis decreased in BasoDTR mice. by Kunie Matsuoka (400418)

“…<p>(A) BasoDTR mice (n = 4 per group) were treated once i.p. with 25 or 50 µg/kg of DT or PBS at 4 days prior to and were i.v. injected with 500 µg rat anti-FcγRII/III (2.4G2) antibodies in 200 µl PBS. …”

Primary endpoint analysis, i.e., time to first occurrence of combined event of 50% decrease in eGFR or ESRD. by Rozita Mohd (7411322)

Lack of p23 results in decreased epidermal thickness, delayed differentiation and increased rates of proliferation and apoptosis in E18.5 skin. by Marta Madon-Simon (527400)

“…(<b>f</b>) BrdU staining of nuclei indicates increased proliferation in <i>p23</i>^<i>-/-</i> skin sections (** p<0.01; n: WT = 7, <i>p23</i>^<i>-/-</i> = 7). Black bars in panels <b>a</b> and <b>d</b> indicate 50 μm.…”

Association between CVR components^b'*' and depressive status (BDI-II ≥18) in the PREDIMED-PLUS trial. by Sandra Martín-Peláez (11353470)

Subjects:

SMC-specific knockout of Klf5 (smcKlf5^−/−) exacerbates the progression of Ang II–induced AAA by facilitating ROS formation. by Dong Ma (584680)

Baseline characteristics of the study participants. by Sandra Martín-Peláez (11353470)

Subjects:

Flow chart for the analysis of cardiovascular risk and depression in the PREDIMED-PLUS trial. by Sandra Martín-Peláez (11353470)

Subjects:

Pathogenicity of LCLs in 5-week-old NOG mice. by Ken Sagou (1945318)

Cdk5 siRNA knockdown decreased Cdk5 activity, diminished WT1 expression and viable cell numbers, and increased cleaved caspase 3 level. by Ya-Li Zheng (454837)

“…Western blotting analysis showed a decline of WT1 expression in Cdk5 siRNA podocytes (upper panel, lane 2). …”

Anti-transforming growth factor beta (TGFβ) Ab decreased aristolochic acid (AA)-induced reticulum endoplasmic (ER) and mitochondrial (MT) stress protein expression in kidney tissue... by Agnieszka A. Pozdzik (3159222)

“…<p>(<b>a</b>) Tissue lysates from kidney cortex, outer stripe of outer medulla (OSOM) and inner stripe of outer medulla (ISOM) were immunoblotted for p-IRE1α, GRP78, p-eIF2α, CHOP and glyceraldehyd 3-phosphate dehydrogenase (GAPDH) expression. …”

Decreased consumption of methionine sulfoxide (MetO) by the <i>V</i>. <i>cholerae</i> Δ<i>gcvT</i> mutant attenuates virulence by promoting intestinal lipid mobilization and insuli... by Audrey S. Vanhove (4090594)

Pretreatment of β-cells with recombinant CXCL12 improves viability and induces a decrease in PARP-1 activity. by Nevena Grdović (394542)

Decreased remyelination initiation is observed in Scribble cKO mice following focal demyelination in corpus callosum. by Andrew A. Jarjour (343100)

“…<i>n</i> = 3 mice per genotype. * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001 versus Scrib WT CL. Scale bars: A,B,D,E: 2 μm. J,K: 50 μm.</p>…”

Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

“…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC₅₀ concentration of fenretinide during different time points (24–48–72 hours). …”

M344 decreases orthotopic pancreatic tumor growth when used as a treatment alone or in combination with gemcitabine. by Shelby M. Knoche (13833807)

Detailed meta–analyses in untreated hypothyroid patients compared with controls for each HRV parameters: RR intervals, SDNN, RMSSD, pNN50, TP, LF, HF, LF/HF. by Valentin Brusseau (12769704)